Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance - Wikidata - wikimedia - TriplyDB

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance

http://www.wikidata.org/entity/Q33598375

about

The notch ligand JAGGED1 as a target for anti-tumor therapy Notch signaling: its roles and therapeutic potential in hematological malignancies Metastatic colonization by circulating tumour cells The hematopoietic stem cell niche in homeostasis and disease GATA4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopoiesis TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis Microenvironmental regulation of therapeutic response in cancer Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts.Metastasis prevention by targeting the dormant niche.Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.Differentiation of pluripotent stem cells into endothelial cells.Regulation of lung development and regeneration by the vascular system.The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.Control of cancer formation by intrinsic genetic noise and microenvironmental cues.Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis.History and conceptual developments in vascular biology and angiogenesis research: a personal view.Non-canonical NOTCH3 signalling limits tumour angiogenesis.Mesoporous silica nanoparticles in tissue engineering--a perspective.A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders.Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.Concise Review: The Malignant Hematopoietic Stem Cell Niche.The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.A jagged road to lymphoma aggressiveness.Regulation of monocyte cell fate by blood vessels mediated by Notch signalling.Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6.Tumor endothelial cells accelerate tumor metastasis Notch controls endothelial cells CANCER. Tumor angiogenesis, from foe to friend.Self-assembly of vascularized tissue to support tumor explants in vitro.

P2860

Q21129294-9F15D315-53F2-4DCD-A3CB-5441BEE653FE Q26765033-233ABA61-3AF7-4CD5-B106-A5A6D204ED94 Q28076164-E2857A76-C05E-41A4-9987-A3B6BC0DBCF1 Q28082775-0EB086E4-A23F-4F53-B147-84CC94A58503 Q30840166-9723FE23-B121-492C-912D-1AF7870A8913 Q30908891-3649F1BB-7942-48DA-890D-73B204EE71B5 Q33654609-3A43AC6F-788F-4B07-AF8A-CE7ACFD96D5D Q33872400-A628EDAE-8BAF-4F1B-9FA3-291A877F7127 Q35115789-040672F9-E911-45EA-B0D4-330FA9433700 Q35940535-86D045A9-0F97-4108-A89B-321CFDF6A106 Q36607541-6A52D55A-0F40-4F47-8E1A-6D183757D5B2 Q36751751-4D63D6B2-EFB3-428D-9B0F-4ED78D8407B1 Q36829245-688F4A86-F515-476E-9FBB-38A1B7242E35 Q36950818-E20077A7-B2D8-4BA7-8DD3-5C45D6A0ECA9 Q37197906-33B59560-B3A5-42F6-9446-AE495849570F Q37258764-AC119ECF-B130-4F74-B471-31F2B27C8B50 Q37509813-D76FC129-51C7-4D7C-B933-032347FAC4EC Q38376496-AAAE8F55-9FCB-48BD-AF9E-998FEFD52811 Q38430681-7D75A0E2-014A-406C-9A4F-CCF9A742D281 Q38540713-A24EFF45-2FAE-4158-A26A-BF34A15291B9 Q38544198-E34FBE0D-C554-490D-9681-B576138F840A Q38601645-12824BA3-5C7D-4A32-A50E-CF8216F0FA67 Q38652259-D846CEA4-0A91-4A68-8D8C-4F0650FA8192 Q38673797-54CD76EF-F9D5-463A-914A-48B2B2CB841B Q38702716-E5E08C89-509B-42B5-94C3-A48CBE46B1DE Q38720538-F222FABB-E56B-4210-8AA6-18684F5FADD3 Q38770774-9125BA22-8174-4554-A7EE-A2151597EF42 Q38823047-F5E0944B-562B-4DED-8616-739EE49E1CCD Q38849027-C1FCE0EF-F5F3-4F19-A9FE-EB4D2E407F9E Q38854580-95ADCFC7-154E-4CE2-A155-3552DEFAC313 Q38959361-F72D0AE9-029F-418F-8099-B954AF6DC94B Q40064208-21A5AD72-AB26-4A96-89A3-C00290E4E6E1 Q40123829-0D9A2ACE-BA8F-4565-983A-05F83518E57C Q41030514-937ED590-9FCA-4F4F-BEA1-4DE66A10F7E7 Q41093114-76A4BD88-202F-4A01-99B0-9D4822928362 Q41809340-DAFE55F5-C420-4B18-83EE-D8500E8BB90E Q42288631-0E62CE9E-809E-4A46-8C35-B6906FB4202B Q42340853-B0F3489C-578A-4ED7-B8A9-0509D94C68EC Q46851713-F1E5C27C-A256-4550-AF57-71B1585C5190 Q47134043-75E4F05D-AE5C-45F8-A077-0B6759BD3EA7

P2860

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance

http://www.wikidata.org/entity/Q33598375

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@ast

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@en

type

label

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@ast

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@en

prefLabel

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@ast

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@en

P1433

Q33598375-98480DB8-8088-45BC-8DC5-BFD66EDB057F

P1476

Q33598375-9194F8D7-16F1-42FB-BD03-E239EBBB4397

P2093

Q33598375-2D4FE8BD-3227-4490-BDD8-AE78E0014E15

Q33598375-377F354A-3DE1-45FF-A4E7-1EF227B493EB

Q33598375-3B949C55-17E6-416A-B8BC-2B72009A27B5

Q33598375-6E052165-5CEC-4FFB-97B6-CC518466C67E

Q33598375-84DE1E70-F91B-4CB0-8888-A9CFDB7F1C84

Q33598375-99B2D7F1-1D9E-4E55-901F-7537982DDF64

Q33598375-A76F049F-5D1F-4310-9540-AB777C2E6B67

Q33598375-A9006085-85C2-43F1-9B77-9AF067A50C51

Q33598375-C13E05F4-8575-4504-A6A1-4FCBB2086289

Q33598375-DDD2994E-2EBC-4A85-B797-8AD1AB9AE0E8

P2860

Q33598375-00389318-A551-4C62-8669-6711EDE34C88

Q33598375-045A7ADF-C319-4907-88AC-A6CB97B882DF

Q33598375-06AE5FA6-06CC-4207-9861-232D539F5584

Q33598375-08549BE0-FFCE-42E9-9BB5-21A8A19D8FF7

Q33598375-11986F0C-05FD-4BF1-BA15-47A210EC73C9

Q33598375-16E96F87-0345-469F-8734-59BCB4E462AC

Q33598375-1777E1EA-BF2D-4B77-ABF8-BCD8FC142F44

Q33598375-18E8DB28-C7D1-46D3-803C-9BD346F90E15

Q33598375-261520CC-99D9-4B99-A789-762F46D66EE1

Q33598375-2BB08182-9B4F-41DB-A8AB-2DAE8790A92F

P304

Q33598375-F19FFCBA-C6E8-45FD-B060-1A5F7647219F

P31

Q33598375-8775D468-B30E-491D-93B8-73E81CD57BE4

P356

Q33598375-21382694-819A-45EE-A6F0-8FC16190D114

P433

Q33598375-A85B5157-2274-4B52-8986-B9BB69A046CF

P478

Q33598375-48026DFC-1F90-4AD3-8240-321C09780343

P50

Q33598375-7AA13673-B772-492E-BAF6-8F7899AF1BFB

Q33598375-B34424C4-C7DE-4623-9473-488A08B078C6

P577

Q33598375-6C5D18C5-EE77-466F-884A-8015928A5903

P5875

Q33598375-29F15B65-DEC4-4B93-B514-D028C3488E1F

P698

Q33598375-3A83E0FF-12E0-4492-B3E2-4ED0631C7E38

P932

Q33598375-7F296E13-3943-4E60-9BB2-C3B664938747

P356

J.CCR.2014.02.005

P1433

P1476

Angiocrine factors deployed by ...... vasiveness and chemoresistance

@en

P2093

Arash Rafii

http://www.w3.org/2001/XMLSchema#string

Bi-Sen Ding

http://www.w3.org/2001/XMLSchema#string

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

Jason M Butler

http://www.w3.org/2001/XMLSchema#string

Koji Shido

http://www.w3.org/2001/XMLSchema#string

Michael Simons

http://www.w3.org/2001/XMLSchema#string

Peipei Guo

http://www.w3.org/2001/XMLSchema#string

Sharrell B Lee

http://www.w3.org/2001/XMLSchema#string

Stephanie C Casey

http://www.w3.org/2001/XMLSchema#string

Wayne Tam

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

DNA damage-mediated induction of a chemoresistant niche

Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis

Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development

Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome

The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling

Rethinking stroma: lessons from the blood

Molecular mechanisms and clinical applications of angiogenesis

P304

350-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.02.005

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M. Scandura

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260996366

http://www.w3.org/2001/XMLSchema#string

P698

24651014

http://www.w3.org/2001/XMLSchema#string

P932

4017921

http://www.w3.org/2001/XMLSchema#string